Target- |
Mechanism- |
|
|
|
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.CN |
First Approval Date12 Mar 2024 |
100 Clinical Results associated with Chengdu Huaxi Natural Medicine Co., Ltd.
0 Patents (Medical) associated with Chengdu Huaxi Natural Medicine Co., Ltd.
100 Deals associated with Chengdu Huaxi Natural Medicine Co., Ltd.
100 Translational Medicine associated with Chengdu Huaxi Natural Medicine Co., Ltd.